Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer.

MLA

Chen, Qiangda, et al. “Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer.” Advanced Science, vol. 10, no. 33, Nov. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1002/advs.202302498.

APA

Chen, Q., Yin, H., He, J., Xie, Y., Wang, W., Xu, H., Zhang, L., Shi, C., Yu, J., Wu, W., Liu, L., Pu, N., & Lou, W. (2023). Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer. Advanced Science, 10(33), 1–16. https://doi.org/10.1002/advs.202302498

Chicago

Chen, Qiangda, Hanlin Yin, Junyi He, Yuqi Xie, Wenquan Wang, Huaxiang Xu, Lei Zhang, et al. 2023. “Tumor Microenvironment Responsive CD8+ T Cells and Myeloid‐Derived Suppressor Cells to Trigger CD73 Inhibitor AB680‐Based Synergistic Therapy for Pancreatic Cancer.” Advanced Science 10 (33): 1–16. doi:10.1002/advs.202302498.